by In2Pharma | Oct 9, 2025 | News
Belgium As of September 1st, 2025, the Algemene Pharmaceutische Bond (APB – General Pharmaceutical Association in Belgium) has ceased the publication of recommended retail prices (RRP) for products that do not fall under regulated pricing schemes. This decision...
